$2.07+0.98%
2026-10-05 closeLoading chart…
Today's signals · No active technical signal.
Signal details →Lipocine last closed at $2.07 (+0.98%) on 2026-10-05. Listed on Nasdaq. Trailing 12 months PER is -1.4×. Its overall grade ranks 619 of 741 stocks in Healthcare.
About this company
Lipocine last closed at $2.07 (+0.98%) on 2026-10-05. Listed on Nasdaq.
Details →Reported results
Details →
Position in sector
Healthcare · Overall D · 619/741
Valuation grade C+
Related stocks
- AstraZenecaCustomer
신약 상업화·라이선스 파트너 후보로 연결되는 대형 글로벌 제약사
- PfizerCustomer
남성호르몬·비뇨기/내분비 계열 약물 협업 가능성이 있는 대형 제약사
- Novo NordiskCustomer
비만·대사질환 치료제 시장의 주요 대형 제약사로 잠재적 파트너 비교 대상
About Lipocine
- What technical signals does Lipocine (LPCN) have?
- Lipocine current technical signals: no active technical signal.
- Is Lipocine a cup-and-handle pattern?
- No. Lipocine has no valid Cup signal right now.
- What published figures are available for Lipocine?
- Market cap: $11.49M. Trailing 12 months PER: -1.4×. Latest quarter PBR: 0.78×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-06 dataset
Turn what you saw on this name into a strategy
Ask Q about Lipocine, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.
Quantus Signal · live data · not investment advice · Privacy Policy